[1]
Okada DR, Bravo PE, Vita T, Agarwal V, Osborne MT, Taqueti VR, Skali H, Chareonthaitawee P, Dorbala S, Stewart G, Di Carli M, Blankstein R. Isolated cardiac sarcoidosis: A focused review of an under-recognized entity. Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology. 2018 Aug:25(4):1136-1146. doi: 10.1007/s12350-016-0658-1. Epub 2016 Sep 9
[PubMed PMID: 27613395]
[2]
Trivieri MG, Spagnolo P, Birnie D, Liu P, Drake W, Kovacic JC, Baughman R, Fayad ZA, Judson MA. Challenges in Cardiac and Pulmonary Sarcoidosis: JACC State-of-the-Art Review. Journal of the American College of Cardiology. 2020 Oct 20:76(16):1878-1901. doi: 10.1016/j.jacc.2020.08.042. Epub
[PubMed PMID: 33059834]
[3]
Birnie DH, Nery PB, Ha AC, Beanlands RS. Cardiac Sarcoidosis. Journal of the American College of Cardiology. 2016 Jul 26:68(4):411-21. doi: 10.1016/j.jacc.2016.03.605. Epub
[PubMed PMID: 27443438]
[4]
Schupp JC, Freitag-Wolf S, Bargagli E, Mihailović-Vučinić V, Rottoli P, Grubanovic A, Müller A, Jochens A, Tittmann L, Schnerch J, Olivieri C, Fischer A, Jovanovic D, Filipovic S, Videnovic-Ivanovic J, Bresser P, Jonkers R, O'Reilly K, Ho LP, Gaede KI, Zabel P, Dubaniewicz A, Marshall B, Kieszko R, Milanowski J, Günther A, Weihrich A, Petrek M, Kolek V, Keane MP, O'Beirne S, Donnelly S, Haraldsdottir SO, Jorundsdottir KB, Costabel U, Bonella F, Wallaert B, Grah C, Peroš-Golubičić T, Luisetti M, Kadija Z, Pabst S, Grohé C, Strausz J, Vašáková M, Sterclova M, Millar A, Homolka J, Slováková A, Kendrick Y, Crawshaw A, Wuyts W, Spencer L, Pfeifer M, Valeyre D, Poletti V, Wirtz H, Prasse A, Schreiber S, Krawczak M, Müller-Quernheim J. Phenotypes of organ involvement in sarcoidosis. The European respiratory journal. 2018 Jan:51(1):. pii: 1700991. doi: 10.1183/13993003.00991-2017. Epub 2018 Jan 25
[PubMed PMID: 29371378]
[5]
Gilotra NA, Griffin JM, Pavlovic N, Houston BA, Chasler J, Goetz C, Chrispin J, Sharp M, Kasper EK, Chen ES, Blankstein R, Cooper LT, Joyce E, Sheikh FH. Sarcoidosis-Related Cardiomyopathy: Current Knowledge, Challenges, and Future Perspectives State-of-the-Art Review. Journal of cardiac failure. 2022 Jan:28(1):113-132. doi: 10.1016/j.cardfail.2021.06.016. Epub 2021 Jul 11
[PubMed PMID: 34260889]
Level 3 (low-level) evidence
[6]
Chen ES, Moller DR. Etiologies of Sarcoidosis. Clinical reviews in allergy & immunology. 2015 Aug:49(1):6-18. doi: 10.1007/s12016-015-8481-z. Epub
[PubMed PMID: 25771769]
[7]
Hosoda Y, Sasagawa S, Yasuda N. Epidemiology of sarcoidosis: new frontiers to explore. Current opinion in pulmonary medicine. 2002 Sep:8(5):424-8
[PubMed PMID: 12172447]
Level 3 (low-level) evidence
[8]
Newman LS, Rose CS, Bresnitz EA, Rossman MD, Barnard J, Frederick M, Terrin ML, Weinberger SE, Moller DR, McLennan G, Hunninghake G, DePalo L, Baughman RP, Iannuzzi MC, Judson MA, Knatterud GL, Thompson BW, Teirstein AS, Yeager H Jr, Johns CJ, Rabin DL, Rybicki BA, Cherniack R, ACCESS Research Group. A case control etiologic study of sarcoidosis: environmental and occupational risk factors. American journal of respiratory and critical care medicine. 2004 Dec 15:170(12):1324-30
[PubMed PMID: 15347561]
Level 2 (mid-level) evidence
[9]
Kern DG, Neill MA, Wrenn DS, Varone JC. Investigation of a unique time-space cluster of sarcoidosis in firefighters. The American review of respiratory disease. 1993 Oct:148(4 Pt 1):974-80
[PubMed PMID: 8214953]
[10]
Burke WM, Keogh A, Maloney PJ, Delprado W, Bryant DH, Spratt P. Transmission of sarcoidosis via cardiac transplantation. Lancet (London, England). 1990 Dec 22-29:336(8730):1579
[PubMed PMID: 1979389]
[11]
Patel MR, Cawley PJ, Heitner JF, Klem I, Parker MA, Jaroudi WA, Meine TJ, White JB, Elliott MD, Kim HW, Judd RM, Kim RJ. Detection of myocardial damage in patients with sarcoidosis. Circulation. 2009 Nov 17:120(20):1969-77. doi: 10.1161/CIRCULATIONAHA.109.851352. Epub 2009 Nov 2
[PubMed PMID: 19884472]
[12]
Parrish SC, Lin TK, Sicignano NM, Lazarus AA. Sarcoidosis in the United States Military Health System. Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG. 2018:35(3):261-267. doi: 10.36141/svdld.v35i3.6949. Epub 2018 Apr 28
[PubMed PMID: 32476911]
[13]
Sharma OP. Sarcoidosis around the world. Clinics in chest medicine. 2008 Sep:29(3):357-63, vii. doi: 10.1016/j.ccm.2008.03.013. Epub
[PubMed PMID: 18539231]
[14]
Lynch JP 3rd, Hwang J, Bradfield J, Fishbein M, Shivkumar K, Tung R. Cardiac involvement in sarcoidosis: evolving concepts in diagnosis and treatment. Seminars in respiratory and critical care medicine. 2014 Jun:35(3):372-90. doi: 10.1055/s-0034-1376889. Epub 2014 Jul 9
[PubMed PMID: 25007089]
[15]
Dubrey SW, Bell A, Mittal TK. Sarcoid heart disease. Postgraduate medical journal. 2007 Oct:83(984):618-23
[PubMed PMID: 17916869]
[16]
Cha MJ, Seo JW, Oh S, Park EA, Lee SH, Kim MY, Park JY. Indirect pathological indicators for cardiac sarcoidosis on endomyocardial biopsy. Journal of pathology and translational medicine. 2020 Sep:54(5):396-410. doi: 10.4132/jptm.2020.06.10. Epub 2020 Jul 29
[PubMed PMID: 32717775]
[17]
Lagana SM, Parwani AV, Nichols LC. Cardiac sarcoidosis: a pathology-focused review. Archives of pathology & laboratory medicine. 2010 Jul:134(7):1039-46
[PubMed PMID: 20586635]
[18]
Kim JS, Judson MA, Donnino R, Gold M, Cooper LT Jr, Prystowsky EN, Prystowsky S. Cardiac sarcoidosis. American heart journal. 2009 Jan:157(1):9-21. doi: 10.1016/j.ahj.2008.09.009. Epub 2008 Nov 12
[PubMed PMID: 19081391]
[19]
Rybicki BA, Major M, Popovich J Jr, Maliarik MJ, Iannuzzi MC. Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization. American journal of epidemiology. 1997 Feb 1:145(3):234-41
[PubMed PMID: 9012596]
[20]
Houston BA, Mukherjee M. Cardiac sarcoidosis: clinical manifestations, imaging characteristics, and therapeutic approach. Clinical Medicine Insights. Cardiology. 2014:8(Suppl 1):31-7. doi: 10.4137/CMC.S15713. Epub 2014 Nov 19
[PubMed PMID: 25452702]
[21]
Ekström K, Lehtonen J, Nordenswan HK, Mäyränpää MI, Räisänen-Sokolowski A, Kandolin R, Simonen P, Pietilä-Effati P, Alatalo A, Utriainen S, Rissanen TT, Haataja P, Kokkonen J, Vihinen T, Miettinen H, Kaikkonen K, Kerola T, Kupari M. Sudden death in cardiac sarcoidosis: an analysis of nationwide clinical and cause-of-death registries. European heart journal. 2019 Oct 1:40(37):3121-3128. doi: 10.1093/eurheartj/ehz428. Epub
[PubMed PMID: 31230070]
[22]
Wung SF. Bradyarrhythmias: Clinical Presentation, Diagnosis, and Management. Critical care nursing clinics of North America. 2016 Sep:28(3):297-308. doi: 10.1016/j.cnc.2016.04.003. Epub 2016 Jun 22
[PubMed PMID: 27484658]
[23]
Gonzalez VJ, Kyle WB, Allen HD. Cardiac Examination and Evaluation of Murmurs. Pediatrics in review. 2021 Jul:42(7):375-382. doi: 10.1542/pir.2020-000604. Epub
[PubMed PMID: 34210756]
[24]
Llanos O, Hamzeh N. Sarcoidosis. The Medical clinics of North America. 2019 May:103(3):527-534. doi: 10.1016/j.mcna.2018.12.011. Epub 2019 Feb 21
[PubMed PMID: 30955519]
[25]
Kusano KF, Satomi K. Diagnosis and treatment of cardiac sarcoidosis. Heart (British Cardiac Society). 2016 Feb:102(3):184-90. doi: 10.1136/heartjnl-2015-307877. Epub 2015 Dec 7
[PubMed PMID: 26643814]
[26]
Burstow DJ, Tajik AJ, Bailey KR, DeRemee RA, Taliercio CP. Two-dimensional echocardiographic findings in systemic sarcoidosis. The American journal of cardiology. 1989 Feb 15:63(7):478-82
[PubMed PMID: 2916434]
[27]
Blankstein R, Kramer CM, Chandrashekhar Y. The Challenges of Diagnosing Cardiac Sarcoidosis. JACC. Cardiovascular imaging. 2017 Dec:10(12):1534-1536. doi: 10.1016/j.jcmg.2017.11.006. Epub
[PubMed PMID: 29216980]
[28]
Bois JP, Muser D, Chareonthaitawee P. PET/CT Evaluation of Cardiac Sarcoidosis. PET clinics. 2019 Apr:14(2):223-232. doi: 10.1016/j.cpet.2018.12.004. Epub 2019 Feb 1
[PubMed PMID: 30826020]
[29]
Schwartz RG, Malhotra S. Optimizing cardiac sarcoid imaging with FDG PET: Lessons from studies of physiologic regulation of myocardial fuel substrate utilization. Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology. 2020 Apr:27(2):490-493. doi: 10.1007/s12350-018-1438-x. Epub 2018 Sep 17
[PubMed PMID: 30225815]
[30]
Blankstein R, Osborne M, Naya M, Waller A, Kim CK, Murthy VL, Kazemian P, Kwong RY, Tokuda M, Skali H, Padera R, Hainer J, Stevenson WG, Dorbala S, Di Carli MF. Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis. Journal of the American College of Cardiology. 2014 Feb 4:63(4):329-36. doi: 10.1016/j.jacc.2013.09.022. Epub 2013 Oct 16
[PubMed PMID: 24140661]
[31]
Kusano KF. Effect of corticosteroid on arrhythmic events in patients with cardiac sarcoidosis. Journal of cardiology. 2013 Nov:62(5):326-7. doi: 10.1016/j.jjcc.2013.09.004. Epub 2013 Oct 27
[PubMed PMID: 24169440]
[32]
Kandolin R, Lehtonen J, Airaksinen J, Vihinen T, Miettinen H, Ylitalo K, Kaikkonen K, Tuohinen S, Haataja P, Kerola T, Kokkonen J, Pelkonen M, Pietilä-Effati P, Utrianen S, Kupari M. Cardiac sarcoidosis: epidemiology, characteristics, and outcome over 25 years in a nationwide study. Circulation. 2015 Feb 17:131(7):624-32. doi: 10.1161/CIRCULATIONAHA.114.011522. Epub 2014 Dec 19
[PubMed PMID: 25527698]
[33]
Birnie DH, Sauer WH, Bogun F, Cooper JM, Culver DA, Duvernoy CS, Judson MA, Kron J, Mehta D, Cosedis Nielsen J, Patel AR, Ohe T, Raatikainen P, Soejima K. HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. Heart rhythm. 2014 Jul:11(7):1305-23. doi: 10.1016/j.hrthm.2014.03.043. Epub 2014 May 9
[PubMed PMID: 24819193]
Level 3 (low-level) evidence
[34]
Doltra A, Amundsen BH, Gebker R, Fleck E, Kelle S. Emerging concepts for myocardial late gadolinium enhancement MRI. Current cardiology reviews. 2013 Aug:9(3):185-90
[PubMed PMID: 23909638]
[35]
Philips B, Madhavan S, James CA, te Riele AS, Murray B, Tichnell C, Bhonsale A, Nazarian S, Judge DP, Calkins H, Tandri H, Cheng A. Arrhythmogenic right ventricular dysplasia/cardiomyopathy and cardiac sarcoidosis: distinguishing features when the diagnosis is unclear. Circulation. Arrhythmia and electrophysiology. 2014 Apr:7(2):230-6. doi: 10.1161/CIRCEP.113.000932. Epub 2014 Mar 1
[PubMed PMID: 24585727]
[36]
Vasaiwala SC, Finn C, Delpriore J, Leya F, Gagermeier J, Akar JG, Santucci P, Dajani K, Bova D, Picken MM, Basso C, Marcus F, Wilber DJ. Prospective study of cardiac sarcoid mimicking arrhythmogenic right ventricular dysplasia. Journal of cardiovascular electrophysiology. 2009 May:20(5):473-6. doi: 10.1111/j.1540-8167.2008.01351.x. Epub 2008 Nov 11
[PubMed PMID: 19017339]
[37]
Tandri H, Castillo E, Ferrari VA, Nasir K, Dalal D, Bomma C, Calkins H, Bluemke DA. Magnetic resonance imaging of arrhythmogenic right ventricular dysplasia: sensitivity, specificity, and observer variability of fat detection versus functional analysis of the right ventricle. Journal of the American College of Cardiology. 2006 Dec 5:48(11):2277-84
[PubMed PMID: 17161260]
[38]
Anderson LJ, Holden S, Davis B, Prescott E, Charrier CC, Bunce NH, Firmin DN, Wonke B, Porter J, Walker JM, Pennell DJ. Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. European heart journal. 2001 Dec:22(23):2171-9
[PubMed PMID: 11913479]
[39]
Prasse A. The Diagnosis, Differential Diagnosis, and Treatment of Sarcoidosis. Deutsches Arzteblatt international. 2016 Aug 22:113(33-34):565-74. doi: 10.3238/arztebl.2016.0565. Epub
[PubMed PMID: 27598883]
[40]
Chiu CZ, Nakatani S, Zhang G, Tachibana T, Ohmori F, Yamagishi M, Kitakaze M, Tomoike H, Miyatake K. Prevention of left ventricular remodeling by long-term corticosteroid therapy in patients with cardiac sarcoidosis. The American journal of cardiology. 2005 Jan 1:95(1):143-6
[PubMed PMID: 15619415]
[41]
Hulten E, Agarwal V, Cahill M, Cole G, Vita T, Parrish S, Bittencourt MS, Murthy VL, Kwong R, Di Carli MF, Blankstein R. Presence of Late Gadolinium Enhancement by Cardiac Magnetic Resonance Among Patients With Suspected Cardiac Sarcoidosis Is Associated With Adverse Cardiovascular Prognosis: A Systematic Review and Meta-Analysis. Circulation. Cardiovascular imaging. 2016 Sep:9(9):e005001. doi: 10.1161/CIRCIMAGING.116.005001. Epub
[PubMed PMID: 27621357]
Level 1 (high-level) evidence
[42]
Velangi PS, Chen KA, Kazmirczak F, Okasha O, von Wald L, Roukoz H, Farzaneh-Far A, Markowitz J, Nijjar PS, Bhargava M, Perlman D, Akçakaya M, Shenoy C. Right Ventricular Abnormalities on Cardiovascular Magnetic Resonance Imaging in Patients With Sarcoidosis. JACC. Cardiovascular imaging. 2020 Jun:13(6):1395-1405. doi: 10.1016/j.jcmg.2019.12.011. Epub 2020 Jan 15
[PubMed PMID: 31954639]